卡普赛西诺类药物及其对癌症的影响:从分子尺度上推断的"双刃剑"
Francisco Luján-Méndez1, Octavio Roldán-Padrón1, J Eduardo Castro-Ruíz2
1Laboratorio de Biología Celular y Molecular, Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Av. De las Ciencias s/n, Juriquilla, Querétaro 76230, Querétaro, Mexico.
Cells
|November 10, 2023
概括
中的酸在癌症中表现出双重作用,通过细胞毒性和免疫支持作为抗瘤剂,但也可能促进癌症的进展. 进一步的研究澄清了它们复杂的作用和治疗潜力.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 癌症生物学 癌症生物学
- 自然产品化学 自然产品化学
背景情况:
- 卡普赛奇诺酸,来自 (Capsicum spp. ),是TRPV1的激动剂,负责刺痛性.
- 广泛的研究强调了素的多方面的生物活性,特别是通过细胞毒性和免疫辅助作用对许多癌症的抗瘤特性.
- 由于其"双刃剑"的作用,西类药物在药理上的使用受到争议,可能与治疗益处一起促进表皮细胞-介质细胞过渡.
研究的目的:
- 在各种癌症模型中提供卡普赛辛诺伊德生物活性的最新比较讨论.
- 分析癌症治疗中关于香素的选择性,疗效和安全性数据.
- 提出机械模型来解释西类药物在癌症中的二分效应.
主要方法:
- 在实验癌症模型中审查和对现有科学报告对西类生物活性进行比较分析.
- 整合潜在的分子机制和癌症生物学原则.
- 讨论与卡普赛辛诺酸在癌症中的免疫调节作用相关的体内证据.
主要成果:
- 卡普赛类药物对癌症表现出复杂的影响,显示出抗瘤性质,但也显示出潜在的促癌作用.
- 在不同癌症类型和实验模型中,选择性,疗效和安全性概况各不相同.
- 机械洞察力揭示了西类的双重性质,影响细胞毒性,免疫反应和上皮-介质细胞过渡.
结论:
- 在瘤学中,西类药物具有复杂的治疗特征,需要仔细考虑它们的"双刃剑"性质.
- 了解它们二分效应的机制基础对于优化它们的潜在临床应用至关重要.
- 对其免疫调节特性和精确机制进行进一步的研究是有必要的,以确保安全有效的使用.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
286
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
286
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K


